Following a federal investigation, AstraZeneca (AZN) has agreed to pay $560,000 to hundreds of sales reps who claimed they were paid less than their colleagues due to racial and gender-based discrimination.
The U.S. Department of Labor found the company paid a lower base salary to 23 Hispanic women primary care sales reps compared to others doing the same job, and 295 women specialty care reps were also paid a lower base salary than men who were sales reps. The discrimination, which is prohibited by government contractors under federal law, occurred between October 2015 and September 2016.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
